Evidence library

Nootropics.

Nootropics combine very different goals: staying awake, changing sleep timing, reducing stress, and improving memory are not interchangeable outcomes. Acute laboratory-task effects also do not establish durable gains in daily cognition.

8 evidence-ranked entries
Important limitations

What the evidence cannot settle yet

Trials are commonly small, short, and sensitive to dose, baseline sleep, extract, and the cognitive test selected. Product-specific botanical findings and approved uses of prescription medicines should not be generalized to healthy-user enhancement.

Safety themes

Risks depend on the intervention

Sleep disruption, sedation, anxiety, cardiovascular effects, medicine interactions, and inconsistent supplement contents recur across the category. Prescription status and anti-doping rules also matter for some entries.

Strongest current evidence

Strong evidence leads this category

Ratings compare confidence in each entry's stated benefit—not whether every intervention is appropriate or recommended.

How ratings work
Browse the evidence

Every nootropics entry

Sorted from stronger to weaker evidence.

Open Caffeine
Strong
Nootropics

Caffeine

A well-studied stimulant that reliably improves alertness and attention, with sleep disruption and tolerance as the main tradeoffs.

Open Melatonin
Moderate
Nootropics

Melatonin

A circadian-timing hormone useful for jet lag and selected sleep-timing problems, with only small average effects in chronic insomnia.

Open Caffeine + L-Theanine
Emerging
Nootropics

Caffeine + L-Theanine

A tea-derived pairing with evidence for small, short-term attention benefits in controlled laboratory tasks.

Open Bacopa Monnieri
Emerging
Nootropics

Bacopa Monnieri

A traditional herbal extract with inconsistent modern evidence for memory and attention and meaningful variation between products.

Open Modafinil
Emerging
Nootropics

Modafinil

A prescription wakefulness medicine with only a very small average cognitive effect in rested healthy adults and important medical, interaction, and sporting constraints.

Open Lion's Mane
Emerging
Nootropics

Lion's Mane

A popular medicinal mushroom with intriguing preclinical biology but mixed, tiny, and product-specific human cognition studies.

Open Ashwagandha
Emerging
Nootropics

Ashwagandha

A traditional botanical with small short-term stress and sleep trials, substantial product variation, and uncommon liver and thyroid risks.

Open Ginkgo Biloba
Insufficient
Nootropics

Ginkgo Biloba

A widely marketed botanical that has not prevented dementia or slowed normal cognitive decline in large, rigorous trials.